Please login to the form below

Not currently logged in
Email:
Password:

Iptacopan

This page shows the latest Iptacopan news and features for those working in and with pharma, biotech and healthcare.

Novartis’ iptacopan shows promise as rare blood disease treatment in phase 3 study

Novartis’ iptacopan shows promise as rare blood disease treatment in phase 3 study

Novartis has announced detailed results from its pivotal phase 3 APPLY-PNH trial, in which its oral monotherapy iptacopan demonstrated superiority over anti-C5 therapy in adult patients with paroxysmal nocturnal ... Results from the study, which the

Latest news

More from news
Approximately 4 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...